Evofem Biosciences Announces Financial Results for the First Quarter of 2024
Provided By PR Newswire
Last update: May 15, 2024
SAN DIEGO, May 15, 2024 /PRNewswire/ -- The company behind the hormone-free contraceptive Phexxi® (lactic acid, citric acid and potassium bitartrate), Evofem Biosciences, Inc. ("Evofem" or "the Company") (OTCQB: EVFM) today announced financial results for the first quarter of 2024. Highlights of and since the quarter include:
Read more at prnewswire.com
